PE Firm Kohlberg and Mubadala Sign a Definitive Agreement to Acquire Majority Stake in PCI Pharma Services
Posted on 08/25/2020
Revealed on August 24, 2020, Kohlberg & Company, LLC acquired a majority stake in PCI Pharma Services, a pharmaceutical and biopharmaceutical global supply chain solutions provider, and portfolio company of Partners Group. In addition, Mubadala Investment Company also became a minority investor in PCI Pharma Services in the deal. Following the sale to private equity firm Kohlberg and Mubadala, Partners Group will retain a meaningful minority equity stake in PCI Pharma Services. The terms of the transaction are not disclosed.
Partners Group, the global private markets investment manager, has agreed to the sale of its majority equity stake in PCI Pharma Services on behalf of its clients and alongside its investment partners Thomas H. Lee Partners and Frazier Healthcare Partners.
PCI Pharma Services is headquartered in Philadelphia, Pennsylvania and employs around 3,900 people globally.
Jefferies LLC served as lead financial advisor to PCI and Morgan Stanley & Co LLC served as co-advisor.
Centerview Partners LLC served as financial advisor to the Kohlberg-Mubadala consortium.
On June 1, 2016, Partners Group bought PCI Pharma Services on behalf of its clients from Frazier Healthcare Partners. Frazier Healthcare Partners acquired PCI in 2012. When the deal was done, Frazier Healthcare Partners retained a minority stake in PCI Pharma Services.